CA1324962C - Compositions et methodes pour retarder les effets du vieillissement de la peau - Google Patents

Compositions et methodes pour retarder les effets du vieillissement de la peau

Info

Publication number: CA1324962C
Authority: CA; Canada
Prior art keywords: skin; vitamin; acid; aging; vehicle
Prior art date: 1985-07-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA 500485

Other languages

English (en)

Inventor

Albert M. Kligman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-26

Filing date

1986-01-28

Publication date

1993-12-07

1985-07-26 Priority claimed from US06/759,505 external-priority patent/US4603146A/en

1986-01-28 Application filed by Individual filed Critical Individual

1986-01-28 Priority to CA 500485 priority Critical patent/CA1324962C/fr

1993-12-07 Application granted granted Critical

1993-12-07 Publication of CA1324962C publication Critical patent/CA1324962C/fr

2010-12-07 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 13
230000000979 retarding effect Effects 0.000 title claims abstract description 6
230000032683 aging Effects 0.000 title abstract description 15
230000000694 effects Effects 0.000 title abstract description 15
238000000034 method Methods 0.000 title abstract description 10
210000003491 skin Anatomy 0.000 claims abstract description 77
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 54
229930002330 retinoic acid Natural products 0.000 claims abstract description 30
210000002615 epidermis Anatomy 0.000 claims abstract description 17
230000002159 abnormal effect Effects 0.000 claims abstract description 16
102000008186 Collagen Human genes 0.000 claims abstract description 15
108010035532 Collagen Proteins 0.000 claims abstract description 15
229920001436 collagen Polymers 0.000 claims abstract description 15
239000000835 fiber Substances 0.000 claims abstract description 13
210000004204 blood vessel Anatomy 0.000 claims abstract description 10
210000004177 elastic tissue Anatomy 0.000 claims abstract description 9
230000008472 epithelial growth Effects 0.000 claims abstract description 9
230000007794 irritation Effects 0.000 claims abstract description 9
230000006866 deterioration Effects 0.000 claims abstract description 7
239000003974 emollient agent Substances 0.000 claims abstract description 4
230000001815 facial effect Effects 0.000 claims abstract description 4
230000015572 biosynthetic process Effects 0.000 claims description 9
231100000252 nontoxic Toxicity 0.000 claims description 5
230000003000 nontoxic effect Effects 0.000 claims description 5
230000000699 topical effect Effects 0.000 claims description 4
229960001727 tretinoin Drugs 0.000 abstract description 25
238000011282 treatment Methods 0.000 abstract description 19
210000004207 dermis Anatomy 0.000 abstract description 11
208000027418 Wounds and injury Diseases 0.000 abstract description 10
230000006378 damage Effects 0.000 abstract description 9
206010051246 Photodermatosis Diseases 0.000 abstract description 7
230000008845 photoaging Effects 0.000 abstract description 7
230000004069 differentiation Effects 0.000 abstract description 6
208000014674 injury Diseases 0.000 abstract description 6
230000002829 reductive effect Effects 0.000 abstract description 6
208000000069 hyperpigmentation Diseases 0.000 abstract description 5
230000003810 hyperpigmentation Effects 0.000 abstract description 5
238000009115 maintenance therapy Methods 0.000 abstract description 5
230000037303 wrinkles Effects 0.000 abstract description 4
210000002919 epithelial cell Anatomy 0.000 abstract description 3
230000002085 persistent effect Effects 0.000 abstract description 3
210000000601 blood cell Anatomy 0.000 abstract description 2
230000006735 deficit Effects 0.000 abstract description 2
230000002500 effect on skin Effects 0.000 abstract description 2
230000008833 sun damage Effects 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 15
239000003981 vehicle Substances 0.000 description 10
239000000126 substance Substances 0.000 description 8
230000017531 blood circulation Effects 0.000 description 7
239000002253 acid Substances 0.000 description 6
239000000049 pigment Substances 0.000 description 6
206010052428 Wound Diseases 0.000 description 5
206010000496 acne Diseases 0.000 description 5
230000009286 beneficial effect Effects 0.000 description 5
239000006071 cream Substances 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
210000002950 fibroblast Anatomy 0.000 description 5
230000012010 growth Effects 0.000 description 5
XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
230000036770 blood supply Effects 0.000 description 4
230000007423 decrease Effects 0.000 description 4
210000001339 epidermal cell Anatomy 0.000 description 4
230000035876 healing Effects 0.000 description 4
230000006872 improvement Effects 0.000 description 4
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
206010003694 Atrophy Diseases 0.000 description 3
229920002683 Glycosaminoglycan Polymers 0.000 description 3
206010040844 Skin exfoliation Diseases 0.000 description 3
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
230000005856 abnormality Effects 0.000 description 3
208000009621 actinic keratosis Diseases 0.000 description 3
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
230000004075 alteration Effects 0.000 description 3
230000037444 atrophy Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
231100000021 irritant Toxicity 0.000 description 3
239000002085 irritant Substances 0.000 description 3
210000002752 melanocyte Anatomy 0.000 description 3
239000003883 ointment base Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
235000019155 vitamin A Nutrition 0.000 description 3
239000011719 vitamin A Substances 0.000 description 3
229940045997 vitamin a Drugs 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
208000002874 Acne Vulgaris Diseases 0.000 description 2
239000004264 Petrolatum Substances 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000001010 compromised effect Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
230000000622 irritating effect Effects 0.000 description 2
230000001050 lubricating effect Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
229940066842 petrolatum Drugs 0.000 description 2
235000019271 petrolatum Nutrition 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
230000001953 sensory effect Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
230000036561 sun exposure Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
230000024883 vasodilation Effects 0.000 description 2
238000004383 yellowing Methods 0.000 description 2
OFNXOACBUMGOPC-HZYVHMACSA-N 5'-hydroxystreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](CO)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O OFNXOACBUMGOPC-HZYVHMACSA-N 0.000 description 1
QFIIYGZAUXVPSZ-UHFFFAOYSA-N 8-(2,4-dihydroxy-6-methylanilino)-2-(2,4-dihydroxy-6-methylphenyl)imino-7-hydroxy-1,9-dimethyldibenzofuran-3-one Chemical compound CC1=CC(=CC(=C1NC2=C(C3=C(C=C2O)OC4=CC(=O)C(=NC5=C(C=C(C=C5C)O)O)C(=C43)C)C)O)O QFIIYGZAUXVPSZ-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
206010002983 Apocrine miliaria Diseases 0.000 description 1
BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
208000005080 Benign Migratory Glossitis Diseases 0.000 description 1
208000003643 Callosities Diseases 0.000 description 1
206010008570 Chloasma Diseases 0.000 description 1
208000032544 Cicatrix Diseases 0.000 description 1
208000002506 Darier Disease Diseases 0.000 description 1
206010013786 Dry skin Diseases 0.000 description 1
206010058314 Dysplasia Diseases 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
241000490229 Eucephalus Species 0.000 description 1
208000014771 Fox-Fordyce Disease Diseases 0.000 description 1
101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
208000002260 Keloid Diseases 0.000 description 1
102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 description 1
206010023347 Keratoacanthoma Diseases 0.000 description 1
206010023369 Keratosis follicular Diseases 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
208000003351 Melanosis Diseases 0.000 description 1
206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
241000795633 Olea <sea slug> Species 0.000 description 1
239000004218 Orcein Substances 0.000 description 1
206010033554 Palmoplantar keratoderma Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
206010067155 Reactive perforating collagenosis Diseases 0.000 description 1
108010081750 Reticulin Proteins 0.000 description 1
208000009163 Sebaceous of Jadassohn Nevus Diseases 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
206010043957 Tongue geographic Diseases 0.000 description 1
241000159243 Toxicodendron radicans Species 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
201000010272 acanthosis nigricans Diseases 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
229940041181 antineoplastic drug Drugs 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
210000000270 basal cell Anatomy 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000008294 cold cream Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
229940117173 croton oil Drugs 0.000 description 1
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
230000035614 depigmentation Effects 0.000 description 1
231100001030 dermal change Toxicity 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
230000037336 dry skin Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
238000004299 exfoliation Methods 0.000 description 1
238000005562 fading Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
201000003860 geographic tongue Diseases 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
239000008311 hydrophilic ointment Substances 0.000 description 1
OFNXOACBUMGOPC-UHFFFAOYSA-N hydroxystreptomycin Natural products CNC1C(O)C(O)C(CO)OC1OC1C(C=O)(O)C(CO)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O OFNXOACBUMGOPC-UHFFFAOYSA-N 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
206010021198 ichthyosis Diseases 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
OKPOKMCPHKVCPP-UHFFFAOYSA-N isoorientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(OC)=C(O)C=C3CCN2C)=C1 OKPOKMCPHKVCPP-UHFFFAOYSA-N 0.000 description 1
210000001117 keloid Anatomy 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
201000004607 keratosis follicularis Diseases 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
201000011486 lichen planus Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
208000021039 metastatic melanoma Diseases 0.000 description 1
231100000067 mild irritant Toxicity 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
208000008588 molluscum contagiosum Diseases 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000002674 ointment Substances 0.000 description 1
235000019248 orcein Nutrition 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
201000008743 palmoplantar keratosis Diseases 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
230000034918 positive regulation of cell growth Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000026416 response to pain Effects 0.000 description 1
JTQHYPFKHZLTSH-UHFFFAOYSA-N reticulin Natural products COC1CC(OC2C(CO)OC(OC3C(O)CC(OC4C(C)OC(CC4OC)OC5CCC6(C)C7CCC8(C)C(CCC8(O)C7CC=C6C5)C(C)O)OC3C)C(O)C2OC)OC(C)C1O JTQHYPFKHZLTSH-UHFFFAOYSA-N 0.000 description 1
150000004508 retinoic acid derivatives Chemical class 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000037387 scars Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
201000010153 skin papilloma Diseases 0.000 description 1
239000000344 soap Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000008719 thickening Effects 0.000 description 1
238000012876 topography Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
230000002792 vascular Effects 0.000 description 1
208000030057 verrucous nevus Diseases 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Gerontology & Geriatric Medicine (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA 500485 1985-07-26 1986-01-28 Compositions et methodes pour retarder les effets du vieillissement de la peau Expired - Lifetime CA1324962C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 500485 CA1324962C (fr)	1985-07-26	1986-01-28	Compositions et methodes pour retarder les effets du vieillissement de la peau

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/759,505 US4603146A (en)	1984-05-16	1985-07-26	Methods for retarding the effects of aging of the skin
CA 500485 CA1324962C (fr)	1985-07-26	1986-01-28	Compositions et methodes pour retarder les effets du vieillissement de la peau

Publications (1)

Publication Number	Publication Date
CA1324962C true CA1324962C (fr)	1993-12-07

Family

ID=25670901

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 500485 Expired - Lifetime CA1324962C (fr)	1985-07-26	1986-01-28	Compositions et methodes pour retarder les effets du vieillissement de la peau

Country Status (1)

Country	Link
CA (1)	CA1324962C (fr)

1986
- 1986-01-28 CA CA 500485 patent/CA1324962C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
1997-01-14	MZSU	Surrender

Publication	Publication Date	Title
US4603146A (en)	1986-07-29	Methods for retarding the effects of aging of the skin
AU598454B2 (en)	1990-06-28	Compositions and methods for retarding the effects of aging of the skin
US4877805A (en)	1989-10-31	Methods for treatment of sundamaged human skin with retinoids
US4888342A (en)	1989-12-19	Methods for treatment of sundamaged human skin with retinoids
CA2866527C (fr)	2018-07-03	Utilisation d'esters d'isoeugenol pour le traitement de l'hyperpigmentation
AU599135B2 (en)	1990-07-12	Methods for treatment of sundamaged human skin with retinoids
KR100519638B1 (ko)	2005-10-10	지질 장벽 합성을 강화시키는 조성물 및 그 방법
US10869822B2 (en)	2020-12-22	Compositions for treatment of dermatological diseases and conditions and methods of use thereof
KR20000016635A (ko)	2000-03-25	프로테아제 효소와 산성 완충액 복합물 및 이의용도
USRE36068E (en)	1999-01-26	Methods for treatment of sundamaged human skin with retinoids
EP3490525A1 (fr)	2019-06-05	Produits de soin pour la peau et leurs utilisations
BR112013024572B1 (pt)	2018-02-14	Processo cosmético e uso cosmético de pelo menos um composto de fórmula (I)
JPH04500824A (ja)	1992-02-13	光老化の作用を回復させるための皮膚の治療方法
CA1324962C (fr)	1993-12-07	Compositions et methodes pour retarder les effets du vieillissement de la peau
CA1338840E (fr)	1997-01-14	Compositions et methodes pour retarder les effets du viellissement de la peau
WO2020201377A1 (fr)	2020-10-08	Crème pour le traitement de la peau lésée par le soleil
NZ214997A (en)	1991-07-26	Skin treatment composition containing vitamin a acid
JPS62185005A (ja)	1987-08-13	皮膚の老化作用を抑制する組成物及び方法
HK1150155B (en)	2018-05-25	Topical compositions for treating inflammatory disorders, diseases and conditions
HK1150155A (en)	2011-11-04	Topical compositions for treating inflammatory disorders, diseases and conditions
BR102017010612A2 (pt)	2018-12-04	composição cosmética, método para o cuidado da pele, uso cosmético e produto cosmético para o cuidado da pele